Yue Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yue Zheng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ruiying Zhang
Department of Cardiovascular Surgery, Tianjin Chest Hospital
2 shared publications- Bo Li
Department of Cardiology, PLA Naval Medical Center, Shanghai, China
1 shared publication Chengxiu Zhao
Department of Cardiovascular Surgery, Handan First Hospital
1 shared publicationJianjun Yan
Department of Emergency and Critical Care, Tianjin University Chest Hospital, Tianjin, China
1 shared publicationLimin Wang
School of Medicine, Hebei University of Engineering
1 shared publicationQingliang Chen
Department of Cardiovascular Surgery, Tianjin Chest Hospital
1 shared publication
Latest Publications
- Open Access
- 5 March 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1759091
Senescence-related epicardial adipocyte genes lead to immune infiltration and myocardial infarction progression
Background: After coronary artery disease (CAD)-related myocardial injury, reactivation of the epicardium results in cardiac remodeling via paracrine secretion. However, the senescence-related genomic signature that reflects epicardial adipose tissue (EAT) and immune infiltration is not well understood. Methods: Adipocyte-related differentially expressed genes (DEGs) were identified in EAT and subcutaneous adipose tissue (SAT) from patients with and without CAD. Immune cells and senescence-related DEGs in EATs were identified. A protein-protein interaction network was used to determine the hub genes. To validate these genes, a Gene Expression Omnibus (GEO) dataset investigation, single cell sequencing analysis and the validation of human sub-epicardial adipose and blood samples were performed. To investigate the mechanism, 3T3-L1 cells were used and differentiated to adipocytes and the hub genes were knocked-down and SASPs were determined. Results: A Venn diagram was used to obtain 82 senescence-related DEGs, and the top 15-degree hub genes were explored. After validating using the GEO datasets and human sub-epicardial adipose samples, STAT3, SERPINE1, CDKN2A, DLG4, PTGS2, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH were found to be significantly expressed in the group with severe CAD. The hub genes, including STAT3, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH , were validated to be highly expressed in adipocytes in ischemic cardiomyopathy patients with end-stage heart failure. STAT3, LRP1, PRKCD, CCND2 , and CISH were highly expressed in adipocytes under hypoxia. STAT3, LRP1, PRKCD, CCND2 , and CISH were knocked-down in 3T3-L1 cell lines. SASPs, including IL1α, IL1β, and TNFα , decreased in hypoxic adipocytes after 5 hub genes knockdown. IL6 decreased in hypoxic adipocytes after STAT3, LRP1, and CISH knockdown , while IL6 increased in hypoxic adipocytes after CCND2 knockdown. The joint ROC of all 5 genes expression was 1. Conclusion: These screened SASP hub genes, including STAT3, LRP1, PRKCD, CCND2 , and CISH, may affect cell senescence after hypoxia, thus inducing CAD progression.
- 5 March 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1759091
Open AccessSenescence-related epicardial adipocyte genes lead to immune infiltration and myocardial infarction progression
Background: After coronary artery disease (CAD)-related myocardial injury, reactivation of the epicardium results in cardiac remodeling via paracrine secretion. However, the senescence-related genomic signature that reflects epicardial adipose tissue (EAT) and immune infiltration is not well understood. Methods: Adipocyte-related differentially expressed genes (DEGs) were identified in EAT and subcutaneous adipose tissue (SAT) from patients with and without CAD. Immune cells and senescence-related DEGs in EATs were identified. A protein-protein interaction network was used to determine the hub genes. To validate these genes, a Gene Expression Omnibus (GEO) dataset investigation, single cell sequencing analysis and the validation of human sub-epicardial adipose and blood samples were performed. To investigate the mechanism, 3T3-L1 cells were used and differentiated to adipocytes and the hub genes were knocked-down and SASPs were determined. Results: A Venn diagram was used to obtain 82 senescence-related DEGs, and the top 15-degree hub genes were explored. After validating using the GEO datasets and human sub-epicardial adipose samples, STAT3, SERPINE1, CDKN2A, DLG4, PTGS2, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH were found to be significantly expressed in the group with severe CAD. The hub genes, including STAT3, MDM2, LRP1, IRS2, PRKCD, CCND2 , and CISH , were validated to be highly expressed in adipocytes in ischemic cardiomyopathy patients with end-stage heart failure. STAT3, LRP1, PRKCD, CCND2 , and CISH were highly expressed in adipocytes under hypoxia. STAT3, LRP1, PRKCD, CCND2 , and CISH were knocked-down in 3T3-L1 cell lines. SASPs, including IL1α, IL1β, and TNFα , decreased in hypoxic adipocytes after 5 hub genes knockdown. IL6 decreased in hypoxic adipocytes after STAT3, LRP1, and CISH knockdown , while IL6 increased in hypoxic adipocytes after CCND2 knockdown. The joint ROC of all 5 genes expression was 1. Conclusion: These screened SASP hub genes, including STAT3, LRP1, PRKCD, CCND2 , and CISH, may affect cell senescence after hypoxia, thus inducing CAD progression.
- 12 November 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (2) , 1-13
Ferroptosis-related differentially expressed genes in patients with diabetes
Background Type 2 diabetes mellitus (DM) can lead to multiple organs damage, for instance, lower limbs, kidneys, nerves and heart. We aimed to investigate the differentially expressed genes (DEGs) that might be potential targets for DM patients, which may promote multiple organs damage. Methods GSE95849 and GSE25724 were downloaded and analyzed to obtain DEGs. A Venn diagram was used to obtain the overlapping ferroptosis-related DEGs using the Ferroptosis Database. Enrichment pathway analysis was performed and the hub genes were obtained. Pivotal miRNAs, transcription factors and drugs with the hub genes interactions were also predicted. Human blood samples were utilized to investigate the effects of the hub genes on DM progression. Results Utilizing the Limma package, 3796 up-regulated and 2475 down-regulated DEGs were obtained in GSE25724, while 5101 up-regulated and 842 down-regulated DEGs were obtained in GSE95849. Using Venn diagram, 28 ferroptosis-related DEGs were obtained. The list of ferroptosis-related DEGs was analyzed, which were involved in response to oxidative stress, cellular response to external stimulus, secondary lysosome, autophagosome, Prolactin signaling pathway, Ferroptosis, and IL-17 signaling pathway. In the protein-protein interaction network, the ferroptosis-related DEGs, including STAT3, SRC, MAPK3, CTBB, ELAVL1, PRKAA1, NFE2L2, PTGS2, MAPK1 and EIF2S1, were demonstrated the hub genes using MCC algorithm in CytoHubba plug-in. TFs interactions, miRNA interactions and drugs interactions with hub genes were explored, which demonstrated the drugs of the targets, for instance, PTGS2, RSG4, MAPK1, MAPK3 and PRKAA1.After validation of human blood samples, STAT3, CTBB, MAPK1 and EIF2S1 were validated to be highly expressed in diabetic patients compared to normal individuals. Conclusions The screened hub genes, STAT3, CTBB, MAPK1 and EIF2S1 were validated to be highly expressed in diabetic patients compared to normal individuals, which may be potential therapeutic targets to treat diabetes and improve patients’ prognosis.
- 12 November 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (2) , 1-13
Ferroptosis-related differentially expressed genes in patients with diabetes
Background Type 2 diabetes mellitus (DM) can lead to multiple organs damage, for instance, lower limbs, kidneys, nerves and heart. We aimed to investigate the differentially expressed genes (DEGs) that might be potential targets for DM patients, which may promote multiple organs damage. Methods GSE95849 and GSE25724 were downloaded and analyzed to obtain DEGs. A Venn diagram was used to obtain the overlapping ferroptosis-related DEGs using the Ferroptosis Database. Enrichment pathway analysis was performed and the hub genes were obtained. Pivotal miRNAs, transcription factors and drugs with the hub genes interactions were also predicted. Human blood samples were utilized to investigate the effects of the hub genes on DM progression. Results Utilizing the Limma package, 3796 up-regulated and 2475 down-regulated DEGs were obtained in GSE25724, while 5101 up-regulated and 842 down-regulated DEGs were obtained in GSE95849. Using Venn diagram, 28 ferroptosis-related DEGs were obtained. The list of ferroptosis-related DEGs was analyzed, which were involved in response to oxidative stress, cellular response to external stimulus, secondary lysosome, autophagosome, Prolactin signaling pathway, Ferroptosis, and IL-17 signaling pathway. In the protein-protein interaction network, the ferroptosis-related DEGs, including STAT3, SRC, MAPK3, CTBB, ELAVL1, PRKAA1, NFE2L2, PTGS2, MAPK1 and EIF2S1, were demonstrated the hub genes using MCC algorithm in CytoHubba plug-in. TFs interactions, miRNA interactions and drugs interactions with hub genes were explored, which demonstrated the drugs of the targets, for instance, PTGS2, RSG4, MAPK1, MAPK3 and PRKAA1.After validation of human blood samples, STAT3, CTBB, MAPK1 and EIF2S1 were validated to be highly expressed in diabetic patients compared to normal individuals. Conclusions The screened hub genes, STAT3, CTBB, MAPK1 and EIF2S1 were validated to be highly expressed in diabetic patients compared to normal individuals, which may be potential therapeutic targets to treat diabetes and improve patients’ prognosis.